roche免疫产品原料简介剖析.课件_第1页
roche免疫产品原料简介剖析.课件_第2页
roche免疫产品原料简介剖析.课件_第3页
roche免疫产品原料简介剖析.课件_第4页
roche免疫产品原料简介剖析.课件_第5页
已阅读5页,还剩11页未读 继续免费阅读

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、免疫产品简介picture placeholder第1页,共16页。抗体销量最好的抗体:CKMB、DD、Ferr、Insulin、E2。Roche单抗为冻干品,建议用0.9%的生理盐水溶解,溶解浓度为10mg/ml。溶解液的储存条件: 1 周 (+2 to +8C), 12 周 (-25 to -15C). 请避免反复冻融。第2页,共16页。抗体肿瘤:项目抗体批号备注CEAMABTU2 IgG MABM-TU3 IgG 11 353 713 103 10 777 498 103 鼠源单抗冻干AFPMABM-LJ738 IgG MABM-TU11 IgG 11 492 101 103 11 49

2、2 080 103 鼠源单抗冻干FerrMABM-3.170 IgG MABM-4.184 IgG 11 547 089 103 11 547 119 103 鼠源单抗冻干第3页,共16页。抗体内分泌:项目抗体批号备注LHMABM-11412 IgG MABM-2.406 IgG 11 547 925103 11 547 038103 鼠源单抗冻干FSHMABM-1.303 IgG MABM-W3 IgG 11 493 540103 11 493 531103 鼠源单抗冻干HCGMABM-INN22 IgG MABM-INN2 IgG 11 812 564103 03 116 263103 鼠

3、源单抗冻干PRLMABM-C4E4 IgG MABM-H12G10 IgG 11 458 701103 11 027 689103 鼠源单抗冻干E2PAKK IgG 05 344 255 103兔源多抗液体第4页,共16页。抗体甲功:项目抗体批号备注TSH MABM-1.20 IgG MABM-A8 IgG 10 767 7781 03 11 367 978 103 鼠源单抗冻干T3PABS IgG 10 907 332 103 羊源多抗冻干T4PABS IgG 10 767 794 103 羊源多抗冻干第5页,共16页。抗体其他:项目抗体批号备注Insulin MABM-ST3 IgG MA

4、BM-BM1 IgG 12 208 750 103 12 208 725 103 鼠源单抗冻干CK-MB MABM-7.4.5 IgG MABM-6.12.47 IgG11 719 815 103 11 719 823 103 鼠源单抗冻干D-DimerMABM-1.2.57 IgG MABM-2.1.16 IgG12 156 903 103 12 045 206 103 鼠源单抗冻干IgEMABM-323 IgG MABM-7H8 IgG 11 543 393 103 11 988 204 103 鼠源单抗冻干CRPPABS IgG 11 888 714 103羊源多抗液体第6页,共16页。

5、酶和底物ALP底物项目抗体批号备注ALPAlkaline Phosphatase, EIA Grade10 556 602 103液体酶活3000u/mgALPAlkaline Phosphatase, recombinant, highly active03 137 031 103液体,酶活7000u/mg糖含量20-30%ALPAlkaline Phosphatase, recombinant, highlyactive, carbohydrate reduce03 535 452 103液体,酶活7000u/mg近天然,糖含量5-10%项目抗体批号备注pNPP4-Nitrophenyl

6、Phosphate10 004 847 103结晶粉末BCIP5-Bromo-4-chloro-3-indolyl-phosphate10 760 978 103结晶粉末第7页,共16页。酶和底物POD底物项目抗体批号备注PODPeroxidase (POD), EIA Grade10 815 462 103冻干酶活225u/mgPODPeroxidase (POD), Grade I10 121 606 103冻干酶活250u/mgPODPeroxidase (POD), Grade II11 378 783 103冻干酶活200u/mgPoly PODPoly POD, EIA Grade

7、11 578 545 103冻干酶活600u/mg项目抗体批号备注TMB3,3,5,5-Tetramethylbenzidine10 203 700 103结晶粉末第8页,共16页。放大系统名称英文名称批号备注链霉亲和素 Streptavidin,recombinant11 520 679 103冻干生物素D-Biotin-N-hydroxysuccinimide ester10 734 250 103白色干粉,短链生物素D-Biotinoyl-aminocaproic acid-N-hydroxysuccinimide ester11 003 933 103白色干粉,长链链霉素包被磁珠Str

8、eptavidin Magnetic Particles11 636 502 103悬浊液磁珠直径2um左右裸珠第9页,共16页。干扰消除蛋白非特异性干扰第10页,共16页。非特异性干扰消除蛋白Bovine IgG PABB-IgG (DE)Cat. No. 11293621 Interference reduction in assay system working with polyclonal bovine IgG through blocking of e.g. antibody solid phase interference Basic interference eliminati

9、on. Specials: IgG fraction from bovine plasma, purified by DE chromatography with 5 % aggregated IgGBSA VCat. No. 10738328 Saturation of unoccupied binding sites on the solid phase Basic interference elimination. Specials: Contains no detectable IgGsSheep IgG PABS-IgG (DE)Cat. No. 10717606 Interfere

10、nce reduction in assay system working with polyclonal sheep IgG through blocking of e.g. antibody solid phase interference Basic interference elimination.Rabbit IgG PABK-IgG (DE)Cat. No. 10912280 Interference reduction in assay system working with polyclonal rabbit IgG through blocking of e.g. antib

11、ody solid phase interference Basic interference elimination.第11页,共16页。非特异性干扰消除蛋白BPLA I + IVBovine Plasma AlbuminCat. Nos. 1172 6536 1172 6544 0353 5240 Avoidance of non-specific adsorption or antibody interactions for more complex applications with higher demands on sensitivity. Specials: High purit

12、y plus pH 4.5 treatmentType I: purity HPLC 95 %, low content of steroids, lipids and haptens Type IV: purity HPLC 95 %, Type IV NEW !: purity HPLC 95 %, Protease-free ! 2 more production steps compared to old version.Poly BSA I + IICat. Nos.11866737 + 11816438Due to their own polyvalence they show o

13、ptimal protection against polyvalent interference (e.g. in infectious disease assays). The negative charge also avoids hydrophobic interactions.Specials: Very efficient background signal reduction.Type I - acetylated; diameter 30 nmType II succinylated; diameter 40 nm It is recommended to combine a

14、mono- and a polyvalent reagent !The total amount of non specific IEP is recommended to be at 2-5%.第12页,共16页。特异性干扰-MAK33 家族单体 IEPsNote: The use of a framework-specific IEP is covered by Roche patent.MAK33 IgG (lyo) Cat. No 1200 941 - monoclonal IgG1 antibody with defined specificity - for test formul

15、ations working with intact IgG1 - mainly for elimination of monomeric and specific interferenceIEP-FrameworkCat. No. 03369846 - for elimination of monomeric and highly specific Interference against the framework regions - caused by highly specific and mostly Mab-therapy-induced HAMAS - developed by

16、comparing the amino acid-sequences of different assay antibodies - use identical immunoreactive amino acid sequences in the framework regions of the interference eliminating reagent as in the test antibodies. - recommended for tumor marker, thyroid and cardiac assays.第13页,共16页。特异性干扰-MAK33 家族多聚体IEPs

17、Note: The use of polymerized IEPs is covered by Roche patent.MAK33-IgG1/IgG1 Poly (liquid) Cat. No 1939 661 polymerized version of MAK33 (DSS linker chemistry) for test formulations working with intact IgG1 higher efficiency concerning HAMA interference type 1 (spontaneous HAMAs) mainly for eliminat

18、ion of polymeric and more unspecific interference.MAK33-IgG1/Fab1 Poly (lyo) Cat. No 1368 338 recommended for test systems working with Fab conjugates comparable characteristics as the a.m. MAK33-IgG/IgG1 poly in addition it covers Fab Neo-epitopes mainly for elimination of polymeric and more unspecific interference.Poly MAK IgG2b/Fab2a (lyo) Cat. No 1355 830 recommended for tes

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论